Impact of molecular analysis on the final sarcoma diagnosis

A study on 763 cases collected during a European epidemiological study

Agnes Neuville, Dominique Ranchère-Vince, Angelo Paolo Dei Tos, Maria Cristina Montesco, Isabelle Hostein, Luisa Toffolatti, Frédéric Chibon, Daniel Pissaloux, Laurent Alberti, Anne Valérie Decouvelaere, Sabrina Albert, Carlo Riccardo Rossi, Jean Yves Blay, Jean Michel Coindre

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Sarcomas are rare, heterogenous, and often difficult to classify. A large proportion of sarcomas are associated with specific molecular genetic lesions such as translocations, mutations, and amplifications, which are helpful in the diagnosis of individual cases. However, the exact impact of molecular genetics on the final diagnosis of sarcomas is unknown. In this study, all soft tissue and visceral sarcomas arising in patients living in 3 European regions in 2 countries (representing 13 million inhabitants) were collected and reviewed during 2 consecutive years. A molecular analysis was performed for all suspicions of sarcomas with specific genetic lesions [mutations of KIT/PDGFRA in gastrointestinal stromal tumors (GISTs), reciprocal translocation, or amplification of MDM2 in atypical lipomatous tumors, well-differentiated liposarcoma-dedifferentiated liposarcoma (ALT/WDLPS-DDLPS)]. To evaluate the impact of molecular tests, a premolecular analysis diagnosis was proposed with 3 categories of certainty: certain, probable, or possible. A molecular analysis was performed in 763/1484 tumors corresponding to 295 cases in which GIST was suspected, 248 sarcomas with a suspicion of translocation, and 220 cases in which ALT/WDLPS-DDLPS was suspected. Molecular analysis was found to be useful (confirms a probable diagnosis) in 11 (4%) GISTs, 62 (26%) suspicions of translocation, and 66 (31%) suspicions of ALT/WDLPS-DDLPS; and necessary (allows a possible diagnosis) in 2 (

Original languageEnglish
Pages (from-to)1259-1268
Number of pages10
JournalAmerican Journal of Surgical Pathology
Volume37
Issue number8
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Liposarcoma
Sarcoma
Epidemiologic Studies
Gastrointestinal Stromal Tumors
Molecular Biology
Neoplasms
Mutation

Keywords

  • diagnosis
  • GIST
  • molecular analysis
  • sarcoma

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery

Cite this

Impact of molecular analysis on the final sarcoma diagnosis : A study on 763 cases collected during a European epidemiological study. / Neuville, Agnes; Ranchère-Vince, Dominique; Dei Tos, Angelo Paolo; Cristina Montesco, Maria; Hostein, Isabelle; Toffolatti, Luisa; Chibon, Frédéric; Pissaloux, Daniel; Alberti, Laurent; Decouvelaere, Anne Valérie; Albert, Sabrina; Riccardo Rossi, Carlo; Blay, Jean Yves; Coindre, Jean Michel.

In: American Journal of Surgical Pathology, Vol. 37, No. 8, 08.2013, p. 1259-1268.

Research output: Contribution to journalArticle

Neuville, A, Ranchère-Vince, D, Dei Tos, AP, Cristina Montesco, M, Hostein, I, Toffolatti, L, Chibon, F, Pissaloux, D, Alberti, L, Decouvelaere, AV, Albert, S, Riccardo Rossi, C, Blay, JY & Coindre, JM 2013, 'Impact of molecular analysis on the final sarcoma diagnosis: A study on 763 cases collected during a European epidemiological study', American Journal of Surgical Pathology, vol. 37, no. 8, pp. 1259-1268. https://doi.org/10.1097/PAS.0b013e31828f51b9
Neuville, Agnes ; Ranchère-Vince, Dominique ; Dei Tos, Angelo Paolo ; Cristina Montesco, Maria ; Hostein, Isabelle ; Toffolatti, Luisa ; Chibon, Frédéric ; Pissaloux, Daniel ; Alberti, Laurent ; Decouvelaere, Anne Valérie ; Albert, Sabrina ; Riccardo Rossi, Carlo ; Blay, Jean Yves ; Coindre, Jean Michel. / Impact of molecular analysis on the final sarcoma diagnosis : A study on 763 cases collected during a European epidemiological study. In: American Journal of Surgical Pathology. 2013 ; Vol. 37, No. 8. pp. 1259-1268.
@article{bddd7b3fdb6e4ac68c4fc0f247c94668,
title = "Impact of molecular analysis on the final sarcoma diagnosis: A study on 763 cases collected during a European epidemiological study",
abstract = "Sarcomas are rare, heterogenous, and often difficult to classify. A large proportion of sarcomas are associated with specific molecular genetic lesions such as translocations, mutations, and amplifications, which are helpful in the diagnosis of individual cases. However, the exact impact of molecular genetics on the final diagnosis of sarcomas is unknown. In this study, all soft tissue and visceral sarcomas arising in patients living in 3 European regions in 2 countries (representing 13 million inhabitants) were collected and reviewed during 2 consecutive years. A molecular analysis was performed for all suspicions of sarcomas with specific genetic lesions [mutations of KIT/PDGFRA in gastrointestinal stromal tumors (GISTs), reciprocal translocation, or amplification of MDM2 in atypical lipomatous tumors, well-differentiated liposarcoma-dedifferentiated liposarcoma (ALT/WDLPS-DDLPS)]. To evaluate the impact of molecular tests, a premolecular analysis diagnosis was proposed with 3 categories of certainty: certain, probable, or possible. A molecular analysis was performed in 763/1484 tumors corresponding to 295 cases in which GIST was suspected, 248 sarcomas with a suspicion of translocation, and 220 cases in which ALT/WDLPS-DDLPS was suspected. Molecular analysis was found to be useful (confirms a probable diagnosis) in 11 (4{\%}) GISTs, 62 (26{\%}) suspicions of translocation, and 66 (31{\%}) suspicions of ALT/WDLPS-DDLPS; and necessary (allows a possible diagnosis) in 2 (",
keywords = "diagnosis, GIST, molecular analysis, sarcoma",
author = "Agnes Neuville and Dominique Ranch{\`e}re-Vince and {Dei Tos}, {Angelo Paolo} and {Cristina Montesco}, Maria and Isabelle Hostein and Luisa Toffolatti and Fr{\'e}d{\'e}ric Chibon and Daniel Pissaloux and Laurent Alberti and Decouvelaere, {Anne Val{\'e}rie} and Sabrina Albert and {Riccardo Rossi}, Carlo and Blay, {Jean Yves} and Coindre, {Jean Michel}",
year = "2013",
month = "8",
doi = "10.1097/PAS.0b013e31828f51b9",
language = "English",
volume = "37",
pages = "1259--1268",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Impact of molecular analysis on the final sarcoma diagnosis

T2 - A study on 763 cases collected during a European epidemiological study

AU - Neuville, Agnes

AU - Ranchère-Vince, Dominique

AU - Dei Tos, Angelo Paolo

AU - Cristina Montesco, Maria

AU - Hostein, Isabelle

AU - Toffolatti, Luisa

AU - Chibon, Frédéric

AU - Pissaloux, Daniel

AU - Alberti, Laurent

AU - Decouvelaere, Anne Valérie

AU - Albert, Sabrina

AU - Riccardo Rossi, Carlo

AU - Blay, Jean Yves

AU - Coindre, Jean Michel

PY - 2013/8

Y1 - 2013/8

N2 - Sarcomas are rare, heterogenous, and often difficult to classify. A large proportion of sarcomas are associated with specific molecular genetic lesions such as translocations, mutations, and amplifications, which are helpful in the diagnosis of individual cases. However, the exact impact of molecular genetics on the final diagnosis of sarcomas is unknown. In this study, all soft tissue and visceral sarcomas arising in patients living in 3 European regions in 2 countries (representing 13 million inhabitants) were collected and reviewed during 2 consecutive years. A molecular analysis was performed for all suspicions of sarcomas with specific genetic lesions [mutations of KIT/PDGFRA in gastrointestinal stromal tumors (GISTs), reciprocal translocation, or amplification of MDM2 in atypical lipomatous tumors, well-differentiated liposarcoma-dedifferentiated liposarcoma (ALT/WDLPS-DDLPS)]. To evaluate the impact of molecular tests, a premolecular analysis diagnosis was proposed with 3 categories of certainty: certain, probable, or possible. A molecular analysis was performed in 763/1484 tumors corresponding to 295 cases in which GIST was suspected, 248 sarcomas with a suspicion of translocation, and 220 cases in which ALT/WDLPS-DDLPS was suspected. Molecular analysis was found to be useful (confirms a probable diagnosis) in 11 (4%) GISTs, 62 (26%) suspicions of translocation, and 66 (31%) suspicions of ALT/WDLPS-DDLPS; and necessary (allows a possible diagnosis) in 2 (

AB - Sarcomas are rare, heterogenous, and often difficult to classify. A large proportion of sarcomas are associated with specific molecular genetic lesions such as translocations, mutations, and amplifications, which are helpful in the diagnosis of individual cases. However, the exact impact of molecular genetics on the final diagnosis of sarcomas is unknown. In this study, all soft tissue and visceral sarcomas arising in patients living in 3 European regions in 2 countries (representing 13 million inhabitants) were collected and reviewed during 2 consecutive years. A molecular analysis was performed for all suspicions of sarcomas with specific genetic lesions [mutations of KIT/PDGFRA in gastrointestinal stromal tumors (GISTs), reciprocal translocation, or amplification of MDM2 in atypical lipomatous tumors, well-differentiated liposarcoma-dedifferentiated liposarcoma (ALT/WDLPS-DDLPS)]. To evaluate the impact of molecular tests, a premolecular analysis diagnosis was proposed with 3 categories of certainty: certain, probable, or possible. A molecular analysis was performed in 763/1484 tumors corresponding to 295 cases in which GIST was suspected, 248 sarcomas with a suspicion of translocation, and 220 cases in which ALT/WDLPS-DDLPS was suspected. Molecular analysis was found to be useful (confirms a probable diagnosis) in 11 (4%) GISTs, 62 (26%) suspicions of translocation, and 66 (31%) suspicions of ALT/WDLPS-DDLPS; and necessary (allows a possible diagnosis) in 2 (

KW - diagnosis

KW - GIST

KW - molecular analysis

KW - sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84880570190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880570190&partnerID=8YFLogxK

U2 - 10.1097/PAS.0b013e31828f51b9

DO - 10.1097/PAS.0b013e31828f51b9

M3 - Article

VL - 37

SP - 1259

EP - 1268

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 8

ER -